Clinical Trial Update: A Long-term Safety Study of Infliximab (Remicade)

View source ↗

Summary

The document reports the completion of a long-term safety study of infliximab (Remicade) across rheumatoid arthritis, Crohn's disease, and psoriasis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Psoriasis
• Rheumatoid Arthritis

Drugs mentioned

• Remicade (infliximab)

Snippet

Sponsor: Centocor, Inc. | Conditions: Arthritis, Rheumatoid, Crohn Disease | Status: COMPLETED